View Expired Tender

Get immediate access to tenders like the one below by subscribing now to Tenders Direct. We will set up your personalised profile and send you tender alerts direct to your mailbox as soon as they are published. You will also benefit from having access to historical tenders.

  • Notice Summary
    United Kingdom-Edinburgh: Oncology Generics Medicines
    419678-2018
    The Common Services Agency (more commonly known as NHS National Services Scotlan
    27 September 2018
    29 October 2018
    Contract Notice - Open Procedure
  • Notice Abstract

    This Framework Agreement is for the supply of a range of Oncology Generic Medicines to NHS Scotland, which will be awarded on a product line or lot by lot basis.As detailed below this framework is tendered using 37 Lots:— Lots 1-36 (except 11, 28 and 36): All of the product lines included within each Lot will be grouped together as individual Lots and awarded to a single Framework Participant per Lot.— Lots 11, 28 and 36: Each product line will be treated as an individual Lot and be awarded on a line by line basis. Each Lot will be awarded as a ranked multi-supplier framework to an envisaged maximum of 6 Framework Participants per line.— Lot 37: Each product line within Lot 37 will be treated as an individual Lot and awarded to a single Framework Participant.Tenderers are invited to bid for as many Lots/lines as they wish.The individual descriptions and quantities are detailed within the tender documentation.

  • Notice Details

    Contract notice

    Directive 2014/24/EU - Public Sector Directive

    Directive 2014/24/EU

    Section I: Contracting Change entity

    I.1) Name and addresses

    The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")

    Gyle Square (NSS Head Office), 1 South Gyle Crescent

    Edinburgh

    EH12 9EB

    UK

    Contact person: Linda Downie

    Telephone: +44 1698794410

    E-mail: l.downie@nhs.net

    NUTS: UKM

    Internet address(es)

    Main address: http://www.nhsscotlandprocurement.scot.nhs.uk/

    Address of the buyer profile: http://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883

    I.2) Joint procurement

    The contract is awarded by a central purchasing body

    I.3) Communication

    The procurement documents are available for unrestricted and full direct access, free of charge at:

    https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html


    Additional information can be obtained from the abovementioned address


    Tenders or requests to participate must be sent electronically to:

    https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html


    I.4) Type of the contracting authority

    Body governed by public law

    I.5) Main activity

    Health

    Section II: Object

    II.1) Scope of the procurement

    II.1.1) Title

    Oncology Generics Medicines

    Reference number: NP39718

    II.1.2) Main CPV code

    33600000

     

    II.1.3) Type of contract

    Supplies

    II.1.4) Short description

    This Framework Agreement is for the supply of a range of Oncology Generic Medicines to NHS Scotland, which will be awarded on a product line or lot by lot basis.

    As detailed below this framework is tendered using 37 Lots:

    — Lots 1-36 (except 11, 28 and 36): All of the product lines included within each Lot will be grouped together as individual Lots and awarded to a single Framework Participant per Lot.

    — Lots 11, 28 and 36: Each product line will be treated as an individual Lot and be awarded on a line by line basis. Each Lot will be awarded as a ranked multi-supplier framework to an envisaged maximum of 6 Framework Participants per line.

    — Lot 37: Each product line within Lot 37 will be treated as an individual Lot and awarded to a single Framework Participant.

    Tenderers are invited to bid for as many Lots/lines as they wish.

    The individual descriptions and quantities are detailed within the tender documentation.

    II.1.6) Information about lots

    This contract is divided into lots: Yes

    Tenders may be submitted for all lots

    II.2) Description

    Lot No: 1

    II.2.1) Title

    Lot 1: Bendamustine Powder For Solution For Infusion

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.

    II.2.4) Description of the procurement

    Supply of Bendamustine Powder For Solution For Infusion to NHS Scotland.

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 144 973.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 2

    II.2.1) Title

    Lot 2 Capecitabine Tablets

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.

    II.2.4) Description of the procurement

    Supply of Capecitabine Tablets to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 562 382.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 3

    II.2.1) Title

    Lot 3 Carboplatin Injection

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.

    II.2.4) Description of the procurement

    Supply of Carboplatin Injections to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 535 310.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 4

    II.2.1) Title

    Lot 4 Cisplatin Injection

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.

    II.2.4) Description of the procurement

    Supply of Cisplatin Injections to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 187 043.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 5

    II.2.1) Title

    Lot 5 Cyclophosphamide Injection, Powder For Reconstitution

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.

    II.2.4) Description of the procurement

    Supply of Cyclophosphamide Injection, Powder For Reconstitution to NHS Scotland.

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 145 107.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 6

    II.2.1) Title

    Lot 6 Cytarabine Injections

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.

    II.2.4) Description of the procurement

    Supply of Cytarabine Injections to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 91 421.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 7

    II.2.1) Title

    Lot 7 Dacarbazine Injections

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.

    II.2.4) Description of the procurement

    Supply of Dacarbazine Injections to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 244 296.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 8

    II.2.1) Title

    Lot 8 Disodium Folinate Injection

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.

    II.2.4) Description of the procurement

    Supply of Disodium Folinate Injections to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 297 306.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 9

    II.2.1) Title

    Lot 9 Docetaxel Concentrate For Solution For Infusion

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.

    II.2.4) Description of the procurement

    Supply of Docetaxel Concentrate For Solution For Infusion to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 346 170.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 10

    II.2.1) Title

    Lot 10 Doxorubicin Hydrochloride Injections

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014

    II.2.4) Description of the procurement

    Supply of Doxorubicin Hydrochloride Injections to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 36 951.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 11

    II.2.1) Title

    Lot 11 Imatinib

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.

    II.2.4) Description of the procurement

    The supply of Imatinib to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 2 393 510.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 12

    II.2.1) Title

    Lot 12 Etoposide Injection

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014

    II.2.4) Description of the procurement

    Supply of Etoposide Injection to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 97 159.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 13

    II.2.1) Title

    Lot 13 Fluorouracil 25MG/ML Injection

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014

    II.2.4) Description of the procurement

    Supply of Fluorouracil 25MG/ML Injections to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 72 461.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 14

    II.2.1) Title

    Lot 14 Fluorouracil 50MG/ML Injection

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014

    II.2.4) Description of the procurement

    Supply of Fluorouracil 50MG/ML Injections to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 104 082.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 15

    II.2.1) Title

    Lot 15 Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014

    II.2.4) Description of the procurement

    Supply of Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 1 604.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 16

    II.2.1) Title

    Lot 16 Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014

    II.2.4) Description of the procurement

    Supply of Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 5 296.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 17

    II.2.1) Title

    Lot 17 Gemcitabine Powder For Solution For Infusion Vials

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.

    II.2.4) Description of the procurement

    Supply of Gemcitabine Powder For Solution For Infusion Vials to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 83 318.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 18

    II.2.1) Title

    Lot 18 Idarubicin Hydrochlioride Injection Powder For Reconstitution

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014

    II.2.4) Description of the procurement

    Supply of Idarubicin Hydrochlioride Injection Powder For Reconstitution to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 330 920.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 19

    II.2.1) Title

    Lot 19 Ifosfamide Injection Powder For Reconstitution

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.

    II.2.4) Description of the procurement

    Supply of Ifosfamide Injection Powder For Reconstitution to NHS Scotland.

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 1 864 493.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 20

    II.2.1) Title

    Lot 20 Irinotecan Hydrochloride Injection

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014

    II.2.4) Description of the procurement

    Supply of Irinotecan Hydrochloride Injection to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 168 475.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 21

    II.2.1) Title

    Lot 21 Lanreotide Injection Prefilled Syringes

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014

    II.2.4) Description of the procurement

    Supply of Lanreotide Injection Prefilled Syringes to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 1 831 616.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 22

    II.2.1) Title

    Lot 22 Methotrexate Without Preservatives Injection

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.

    II.2.4) Description of the procurement

    Supply of Methotrexate Without Preservatives Injection to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 360 288.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 23

    II.2.1) Title

    Lot 23 Methotrexate Oral Solution

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.

    II.2.4) Description of the procurement

    Supply of Methotrexate Oral Solution to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 131 200.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 24

    II.2.1) Title

    Lot 24 Mitomycin Injection Powder For Reconstitution

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014

    II.2.4) Description of the procurement

    Supply of Mitomycin Injection Powder For Reconstitution to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 838 091.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 25

    II.2.1) Title

    Lot 25 Octreotide Injection

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014

    II.2.4) Description of the procurement

    Supply of Octreotide Injections to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 173 410.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 26

    II.2.1) Title

    Lot 26 Oxaliplatin Vial Solution

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014

    II.2.4) Description of the procurement

    Supply of Oxaliplatin Vial Solution to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 67 155.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 27

    II.2.1) Title

    Lot 27 Paclitaxel Concentrate For Intravenous Infusion

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.

    II.2.4) Description of the procurement

    Supply of Paclitaxel Concentrate For Intravenous Infusion to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 213 568.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 28

    II.2.1) Title

    Lot 28 Dasatinib

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.

    II.2.4) Description of the procurement

    Supply of Dasatinib to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 9 032 433.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 29

    II.2.1) Title

    Lot 29 Aprepitant

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.

    II.2.4) Description of the procurement

    Supply of Aprepitant to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 627 688.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 30

    II.2.1) Title

    Lot 30 Temozolomide Capsules

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014

    II.2.4) Description of the procurement

    Supply of Temozolomide Capsules to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 172 980.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 31

    II.2.1) Title

    Lot 31 Topotecan Capsules

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.

    II.2.4) Description of the procurement

    Supply of Topotecan Capsules to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 85 452.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 32

    II.2.1) Title

    Lot 32 Topotecan Concentrate For Solution For Infusion

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014

    II.2.4) Description of the procurement

    Supply of Topotecan Concentrate For Solution For Infusion to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 1 517.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 33

    II.2.1) Title

    Lot 33 Vincristine Without Preservatives Injection

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014

    II.2.4) Description of the procurement

    Supply of Vincristine Without Preservatives Injection to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 58 892.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 34

    II.2.1) Title

    Lot 34 Vinorelbine Injection

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014

    II.2.4) Description of the procurement

    Supply of Vinorelbine Injections to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 22 369.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 35

    II.2.1) Title

    Lot 35 Vinorelbine Capsules

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.

    II.2.4) Description of the procurement

    Supply of Vinorelbine Capsules to NHS Scotland

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 1 131 199.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 36

    II.2.1) Title

    Lot 36 Everolimus

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014

    II.2.4) Description of the procurement

    Supply of Everolimus to NHS Scotland.

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 966 978.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Lot No: 37

    II.2.1) Title

    Lot 37 All Other Oncology Generic Products/Presentations

    II.2.2) Additional CPV code(s)

    33600000

    II.2.3) Place of performance

    NUTS code:

    UKM


    Main site or place of performance:

    All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014

    II.2.4) Description of the procurement

    The supply of All Other Oncology Generic Products/Presentations to NHS Scotland.

    Each product line will be treated as an individual lot and awarded to a single supplier for the full lot.

    II.2.5) Award criteria

    Criteria below:

    Quality criterion: Logistics / Weighting: 5

    Price / Weighting:  95

    II.2.6) Estimated value

    Value excluding VAT: 13 160 032.00 GBP

    II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

    Duration in months: 24

    This contract is subject to renewal: Yes

    Description of renewals:

    The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

    II.2.9) Information about the limits on the number of candidates to be invited

    II.2.10) Information about variants

    Variants will be accepted: No

    II.2.11) Information about options

    Options: No

    II.2.12) Information about electronic catalogues

    Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

    II.2.13) Information about European Union funds

    The procurement is related to a project and/or programme financed by European Union funds: No

    Section III: Legal, economic, financial and technical information

    III.1) Conditions for participation

    III.1.1) Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers

    List and brief description of conditions:

    Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015

    III.1.3) Technical and professional ability

    List and brief description of selection criteria:

    (a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by approved by the MHRA for all tendered Goods at the date of submission of the tender;

    (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent;

    (c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design.


    Minimum level(s) of standards required:

    (a) Confirmation of existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Goods at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control;

    (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes;

    (c) Confirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design. Confirmation of sample provision should be provided in the Qualification Envelope of the ITT under Technical and Professional ability: Products.

    III.2) Conditions related to the contract

    Section IV: Procedure

    IV.1) Description

    IV.1.1) Type of procedure

    Open procedure

    IV.1.3) Information about a framework agreement or a dynamic purchasing system

    The procurement involves the establishment of a framework agreement with several operators.

    IV.1.8) Information about Government Procurement Agreement (GPA)

    The procurement is covered by the Government Procurement Agreement: Yes

    IV.2) Administrative information

    IV.2.2) Time limit for receipt of tenders or requests to participate

    Date: 29/10/2018

    Local time: 12:00

    IV.2.4) Languages in which tenders or requests to participate may be submitted

    EN

    IV.2.6) Minimum time frame during which the tenderer must maintain the tender

    Duration in months: 3 (from the date stated for receipt of tender)

    IV.2.7) Conditions for opening of tenders

    Date: 29/10/2018

    Local time: 12:00

    Section VI: Complementary information

    VI.1) Information about recurrence

    This is a recurrent procurement: No

    VI.2) Information about electronic workflows

    Electronic ordering will be used

    Electronic invoicing will be accepted

    Electronic payment will be used

    VI.3) Additional information

    The estimated value referred to in Sections II.I.5 and within each Lot covers the twenty-four (24) months contract duration and the full twenty-four (24) months extension options.

    The buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 11868. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343

    The Contracting Authority does not intend to include a sub-contract clause as part of community benefits (as per Section 25 of the Procurement Reform (Scotland) Act 2014) in this contract for the following reason:

    It is not anticipated that sub-contractors will be used in delivery of this Framework Agreement.

    The Contracting Authority does not intend to include any community benefit requirements in this contract for the following reason:

    No Community Benefits will be deliverable through the award of this contract.

    (SC Ref:554396)

    VI.4) Procedures for review

    VI.4.1) Review body

    The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")

    Gyle Square (NSS Head Office), 1 South Gyle Crescent

    Edinburgh

    EH12 9EB

    UK

    Telephone: +44 1698794410

    Internet address(es)

    URL: http://www.nhsscotlandprocurement.scot.nhs.uk/

    VI.4.3) Review procedure

    Precise information on deadline(s) for review procedures:

    The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the Framework Agreement which notification will contain among other information, a summary of the reasons why the economic operator was unsuccessful. The notification will incorporate a 'standstill period' of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority despatches the notice(s) and the date on which the Authority proposes to conclude the relevant Framework Agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the Framework Agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the Framework Agreement has been entered into include the setting aside of the decision to award the Framework Agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.

    VI.5) Date of dispatch of this notice

    25/09/2018